Osteoporosis and lung transplantation: a prospective study

Area of Science:

• Medical research
• Transplantation medicine
• Bone metabolism

Background:

• Osteoporosis is a common complication following lung transplantation, negatively impacting patient quality of life.
• Pre-transplant bone mineral density (BMD) assessments are crucial for identifying at-risk individuals.

Purpose of the Study:

• To prospectively evaluate bone mineral density (BMD) changes before and after lung transplantation.
• To determine the extent of bone mass loss and the incidence of fractures post-transplant.
• To identify risk factors associated with bone loss in lung transplant recipients.

Main Methods:

• Prospective study of 28 lung transplant candidates and recipients.
• Measurement of BMD at the lumbar spine (LS) and femoral neck (FN) pre-transplant and 6-12 months post-transplant.
• Patients received vitamin D and calcium supplementation; univariate analysis identified risk factors.

Main Results:

• Pre-transplant, patients exhibited moderate to severe bone disease (LS T-score: -1.72, FN T-score: -2.65).
• Within 6-12 months post-transplant, mean BMD decreased by 4.76% at the LS and 5.3% at the FN (p < 0.001 for both).
• 18% of patients experienced osteoporotic fractures post-transplant; cumulative steroid dose correlated with BMD loss.

Conclusions:

• Lung transplantation leads to significant BMD reduction at the lumbar spine and femoral neck within a year.
• This BMD decrease occurs despite standard vitamin D and calcium supplementation.
• The observed bone loss is linked to a notable incidence of post-transplant osteoporotic fractures.